CRV431 decreases diet- and chemical-driven fibrosis in livers of miceJoseph Kuo, Philippe Gallay, Erika Cabrera et al.|Journal of Hepatology|2020Cited by 0
Cyclophilin D knockout promotes cell death pathways in preventing HCC development in a streptozotocin-induced mouse model of diabetes-linked NASHWinston T Stauffer, Philippe Gallay, Robert E. Foster et al.|Journal of Hepatology|2022Cited by 0
Rencofilstat, a pan-cyclophilin inhibitor, exerts diverse metabolic and transcriptional anti-tumor activities in a murine NASH-HCC modelDaren Ure, Philippe Gallay, Robert E. Foster et al.|Journal of Hepatology|2022Cited by 0
Mice lacking Cyclophilin B, but not Cyclophilin A, are significantly protected from the development of major features of NAFLD/NASH in a diet and chemical-induced modelWinston T Stauffer, Philippe Gallay, Daren Ure et al.|Journal of Hepatology|2023Cited by 0